Last reviewed · How we verify
NCT03211260
Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease
NA trial testing EQUISTASI in Freezing of Gait in 42 participants. Terminated before completion.
19 July 2019
Quick facts
| Lead sponsor | ASST Gaetano Pini-CTO |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 42 |
| Start date | 11 December 2017 |
| Primary completion | 19 July 2019 |
| Estimated completion | 19 July 2019 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- EQUISTASI
Conditions studied
- Freezing of Gait — all drugs for Freezing of Gait →
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
ASST Gaetano Pini-CTO — full company profile →
Who can join
Eligibility, any sex, with Freezing of Gait or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Freezing of gait (FOG) is a common disabling condition in Parkinson's disease (PD), causes falls, and impairs quality of life. Therapeutic options for this symptom are limited and of limited efficacy. Besides, the pathophysiology has been not clarified yet. Proprioceptive sensitivity is likely to play a role and recent studies have reported that high-frequency microfocal vibratory stimulation exert a modulatory effect of proprioceptive reflex circuits and could be considered a valuable treatment strategy. However, evidence is not available. The present study was designed to collect preliminary evidence of efficacy of a vibrotactile device (Equistasi) for the treatment of FOG.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03211260
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Freezing of Gait
Currently open trials in the same condition.
- NCT07386015 — Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG) · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07316296 — Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi · Phase 3 · recruiting
- NCT06713265 — Study of the Link Between Freezing of Gait and Oropharyngeal Freezing in Parkinson's Patients · recruiting
- NCT06630702 — Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease · NA · recruiting
Other ASST Gaetano Pini-CTO trials
Trials by the same sponsor.
- NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
- NCT03406988 — Autologous Adipose Tissue in the Treatment of Systemic Sclerosis Digital Ulcers · NA · unknown
- NCT03060928 — Evaluation of Tendon-to-Bone Healing Potential in Arthroscopic Rotator Cuff Repair Through Biological Stimulation · NA · unknown
- NCT03092466 — Early Femoral Block in Elderly With Hip Fracture · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03211260 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ASST Gaetano Pini-CTO
- Last refreshed: 12 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03211260.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing